Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

BBNXBBNX
6 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in BETA BIONICS INC

Yes. Charles Schwab Investment Management holds 350,873 shares of BBNX (Beta Bionics), worth $5.5M, as of its Q2 2026 13F filing. It increased the position by 28,406 shares (+8.8%) from Q1 2026. Charles Schwab Investment Management has held BBNX in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$5.5M

Current Shares

350,873

Total Value Change

+$4.3M

Total Shares Change

+249,259

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
350,873
+8.8%
$5.5M0.0%$15.67
29
2026-Q1
Decreased
322,467
-2.8%
$3.2M0.0%$11.57
0
2025-Q4
Increased
331,623
+0.3%
$10.1M0.0%$31.97
28
2025-Q3
Increased
330,692
+223.5%
$6.6M0.0%$19.85
44
2025-Q2
Increased
102,225
+0.6%
$1.5M0.0%$15.07
26
2025-Q1
New
101,614
-
$1.2M0.0%$11.71
35

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used